| NCT ID | NCT05568199 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Parkinsons Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-03-05 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-03-05 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
By defining the strength and direction of connectivity patterns at rest and during movement across the basal ganglia-thalamocortical (BGTC) network we will characterize the role of individual circuits in motor performance and cognitive function, paving the way for future development of optimization algorithms for DBS that take advantage of this understanding.
Eligibility Criteria
Inclusion Criteria: * Implanted with a DBS system * Existing 7T imagery (either done as standard-of-care or done as part of Noam Harel's study, IRB #1210M22183) * Diagnosed with idiopathic Parkinson's Disease * Minimum age 21 years Exclusion Criteria: * Other significant neurological disorder, as determined by PI * Diagnosis of dementia * Pregnant
Contact & Investigator
Jerrold Vitek, MD, PhD
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT05568199 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Parkinsons Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05568199 currently recruiting?
Yes, NCT05568199 is actively recruiting participants. Contact the research team at beltz070@umn.edu for enrollment information.
Where is the NCT05568199 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT05568199 clinical trial?
NCT05568199 is sponsored by University of Minnesota. The principal investigator is Jerrold Vitek, MD, PhD at University of Minnesota. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.